Chinese english Germany Japanese Korea

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Struktur
1353644-70-8
CAS-Nr.
1353644-70-8
Englisch Name:
(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide
Synonyma:
HMPL309;HMPL 309;HMPL-309;EOS-61583;Theliatinib;Theliatinib (HMPL-309);ThTheliatinib (HMPL-309);HMPL-309;HMPL 309;HMPL309;(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide;Pyrrolo[3,4-b]pyrrole-5(1H)-carboxamide, N-[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]hexahydro-1-methyl-, (3aR,6aR)-
CBNumber:
CB23142246
Summenformel:
C25H26N6O2
Molgewicht:
442.51
MOL-Datei:
1353644-70-8.mol
Request For Quotation

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Eigenschaften

Siedepunkt:
675.6±55.0 °C(Predicted)
Dichte
1.35±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMSO: 5 mg/mL (11.30 mM)
pka
13.59±0.20(Predicted)

Sicherheit

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Chemische Eigenschaften,Einsatz,Produktion Methoden

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

phenyl (4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)carbamate (3aR,6aR)-1-Methyl-hexahydropyrrolo[3,4-b]pyrrole 3-Ethinylanilin

Downstream Produkte

(3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 38)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
HANGZHOU CLAP TECHNOLOGY CO.,LTD 		86-571-88216897,88216896 13588875226
 sales@hzclap.com CHINA 6313 58
InvivoChem 		+1-708-310-1919 +1-13798911105
 sales@invivochem.cn United States 6393 58
Nantong HI-FUTURE Biology Co., Ltd. 		+undefined18051384581
 sales@chemhifuture.com China 3136 58
TargetMol Chemicals Inc. 		+1-781-999-5354
support@targetmol.com United States 19973 58
Zibo Hangyu Biotechnology Development Co., Ltd 		+86-0533-2185556 +8617865335152
 Mandy@hangyubiotech.com China 11013 58
Aladdin Scientific 		+1-833-552-7181
sales@aladdinsci.com United States 57511 58
Wuhan Jingkangen Biomedical Technology Co., Ltd 13720134139 13720134139
 orders@jknbiochem.com China 4957 58
Sichuan Wei Keqi Biological Technology Co., Ltd. 028-81700200 18116577057
 3003855609@qq.com China 7892 56
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696，15000506266 15000506266
 China 4121 55
BOC Sciences 16314854226
 info@bocsci.com United States 9926 65
  • (3aR,6aR)-N-(4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)-1-methylhexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide
  • EOS-61583
  • Theliatinib (HMPL-309)
  • ThTheliatinib (HMPL-309)
  • Theliatinib
  • HMPL 309
  • HMPL309
  • HMPL-309
  • HMPL-309;HMPL 309;HMPL309
  • ATP-competitive,inhibit,EGFR,ERK,cancer,esophageal,Epidermal growth factor receptor,HMPL-309,anti-tumor,Inhibitor,ErbB-1,HMPL309,Theliatinib,HER1,HMPL 309,orally,Xiliertinib,AKT,phosphorylation
  • Pyrrolo[3,4-b]pyrrole-5(1H)-carboxamide, N-[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]hexahydro-1-methyl-, (3aR,6aR)-
  • 1353644-70-8
Copyright 2019 © ChemicalBook. All rights reserved